An Official Website of the United States Government
Company Information:
Name:
XL SCI-TECH, INC.
Address:
3100 GEORGE WASHINGTON WAY
RICHLAND, WA 99354-1663
RICHLAND, WA 99354-1663
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
TIMED BIORESORBABLE Y 90 MICROSPHERES FOR RADIOTHERAPY
Award Year / Program / Phase:
1997 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Peng, yongren b
Award Amount:
$99,146.00
PRODUCTION OF Y90 MICROSPHERES FOR RADIATION THERAPY
Award Year / Program / Phase:
1998 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Peng, Yongren B
Award Amount:
$99,922.00
N/A
Award Year / Program / Phase:
1999 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Peng yongren b
Award Amount:
$839,283.00
Production of Y-90 Microspheres for Radiation Therapy
Award Year / Program / Phase:
2001 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Yongren B. Peng
Award Amount:
$0.00
Abstract:
DESCRIPTION (Provided by Applicant): The feasibility of continuous and
economical microfabrication of timed-bioresorbable glass microspheres
containing yttrium-90 (Y-90) at therapeutic concentrations has been
successfully demonstrated using Y-89… More
Production of Y-90 Microspheres for Radiation Therapy
Award Year / Program / Phase:
2001 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Yongren B. Peng
Award Amount:
$420,423.00
Abstract:
DESCRIPTION (Provided by Applicant): The feasibility of continuous and
economical microfabrication of timed-bioresorbable glass microspheres
containing yttrium-90 (Y-90) at therapeutic concentrations has been
successfully demonstrated using Y-89… More
TIMED-BIORESORBABLE RADIOSEEDS FOR PROSTATE CANCER
Award Year / Program / Phase:
2001 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Yongren B. Peng
Award Amount:
$108,863.00
Abstract:
Radioisotopes used for prostate cancer treatment are predominately photon/gamma-emitters (I-125, Pd-103, Ir-192). Both temporary and permanent gamma-emitting radioseeds have gained acceptance for interstitial implantation in the prostate. Due to greater tissue penetration, however, gamma radiation… More
CONTROLLED CELL MEMBRANE DISRUPTION:GENE TRANSFECTION
Award Year / Program / Phase:
2002 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Yongren B. Peng
Award Amount:
$111,719.00
Abstract:
A cell population can be made amenable to the uptake of exogenous molecules by rupturing the plasma membranes of the cells. This allows the incorporation of the desired gene molecules into targeted cells. Over- rupturing of cell membranes will lead to undesirable loss of viability of the cell… More
Low Cost Manufacturing Process for Sodium Iodide Detectors
Award Year / Program / Phase:
2005 / SBIR / Phase I
Agency / Branch:
DOD / DTRA
Principal Investigator:
Y. B. Peng, President
Award Amount:
$99,981.00
Abstract:
An unconventional, continuous, and flexible manufacturing process is proposed for the production of sodium iodide detectors. The steps of crystal growing and substantially simplified detector machining are integrated into one streamline process based on proven techniques with minimal capital… More
Absorbable and Low-Cost Radioseeds for Malignant Tumors
Award Year / Program / Phase:
2006 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Yongren B. Peng
Award Amount:
$146,461.00
Abstract:
DESCRIPTION (provided by applicant): The objective of this Phase I research is to demonstrate the feasibility of creating timed-bioabsorbable Pd-103 seeds for the treatment of prostate tumors. Timed- bioabsorbable seeds have the combined benefits of titanium seeds, high dose rate temporary seeds,… More
Absorbable and Low-Cost Radioseeds for Malignant Tumors
Award Year / Program / Phase:
2007 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Yongren B. Peng
Award Amount:
$792,719.00
Abstract:
DESCRIPTION (provided by applicant): The objective of this Phase I research is to demonstrate the feasibility of creating timed-bioabsorbable Pd-103 seeds for the treatment of prostate tumors. Timed- bioabsorbable seeds have the combined benefits of titani
um seeds, high dose rate temporary seeds,… More
Nano Radioisotope Sources For Targeted Radiation Therapy
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Yongren B. Peng
Award Amount:
$140,370.00
Abstract:
DESCRIPTION (provided by applicant): Radioisotopes used in targeted therapy are often labeled to targeting biomolecules. Different radioisotope and biomolecule usually require different linkage to bind the radioisotope to the targeting biomolecule. This pr
oposed research is to create modular nano… More
PET Enabled Microspheres for Radioembolization of Liver Tumors
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Yongren B. Peng – 509-375-0884
Award Amount:
$191,356.00
Abstract:
DESCRIPTION (provided by applicant): Project Summary/Abstract Current radioembolic Y-90 microspheres have been generally recognized as the state-of-the-art for treating primary and metastatic liver tumors. However, the clinical results vary vastly dueto the lack of accurate diagnostic imaging… More